Alpha, Sharima .
HRN: 07-33-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2025
MEBENDAZOLE 500MG (TAB)
06/25/2025
06/25/2025
PO
500mg
1 Dose
Intestinal Parasitism
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes